Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Health Catalyst (HCAT) Assets (2018 - 2025)

Historic Assets for Health Catalyst (HCAT) over the last 8 years, with Q3 2025 value amounting to $587.1 million.

  • Health Catalyst's Assets fell 2778.7% to $587.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $587.1 million, marking a year-over-year decrease of 2778.7%. This contributed to the annual value of $858.9 million for FY2024, which is 2238.7% up from last year.
  • As of Q3 2025, Health Catalyst's Assets stood at $587.1 million, which was down 2778.7% from $616.2 million recorded in Q2 2025.
  • Over the past 5 years, Health Catalyst's Assets peaked at $891.5 million during Q1 2025, and registered a low of $563.0 million during Q2 2021.
  • Moreover, its 5-year median value for Assets was $752.3 million (2022), whereas its average is $737.9 million.
  • Its Assets has fluctuated over the past 5 years, first surged by 8500.6% in 2021, then tumbled by 2778.7% in 2025.
  • Quarter analysis of 5 years shows Health Catalyst's Assets stood at $832.1 million in 2021, then fell by 9.59% to $752.3 million in 2022, then decreased by 6.71% to $701.8 million in 2023, then grew by 22.39% to $858.9 million in 2024, then tumbled by 31.64% to $587.1 million in 2025.
  • Its last three reported values are $587.1 million in Q3 2025, $616.2 million for Q2 2025, and $891.5 million during Q1 2025.